← Leaderboards
Anny Xiaobo Zhou
Brigham And Women'S Hospital
$14,633,236
Attributed
$23,203,184
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,203,184 · 9
By mechanism
R01$18,709,457 · 6
P01$2,335,763 · 1
R33$1,679,998 · 1
R21$477,966 · 1
Top collaborators
- Edwin K Silverman13 shared
- Michael H. Cho9 shared
- Wenyi Wei4 shared
- Andrew A Wilson3 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Edwin K Silverman$89,199,838
- Vijay K Kuchroo$71,617,613
- Simon C Body$5,470,378
- Craig P Hersh$16,648,360
- Wenyi Wei$20,822,884
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularGenome Wide Association StudyGenesCellsBiologicalEpithelial CellsLungInsightPathway InteractionsIn VivoGeneticMediatingVariantRisk VariantChronic Obstructive Airway DiseaseCigarette SmokingBaseDisease SusceptibilityIn VitroPhenotypeGenetic VariantCell TypePathogenesisComplex
Grant awards (37)
Mechanistic studies of the genetic contribution of desmoplakin to pulmonary fibrosis in alveolar type 2 cells$776,803
R01 · FY2025 · HL
Molecular understanding of the GSDMB-regulated innate immune response$530,529
R01 · FY2025 · HL · contact PI
Mechanistic studies of the genetic contribution of desmoplakin to pulmonary fibrosis in alveolar type 2 cells$764,263
R01 · FY2024 · HL
Metabolic Control of Stemness in lung epithelial progenitors by FAM13A$654,053
R01 · FY2024 · HL · contact PI
Molecular understanding of the GSDMB-regulated innate immune response$640,287
R01 · FY2024 · HL · contact PI
Mechanistic studies of the genetic contribution of desmoplakin to pulmonary fibrosis in alveolar type 2 cells$799,392
R01 · FY2023 · HL
Metabolic Control of Stemness in lung epithelial progenitors by FAM13A$667,400
R01 · FY2023 · HL · contact PI
Integrative Characterization on the function of COPD GWAS gene, HHIP$655,509
R01 · FY2023 · HL · contact PI
Molecular understanding of the GSDMB-regulated innate immune response$653,354
R01 · FY2023 · HL · contact PI
Genetic and Functional Dissection of a Cluster of COPD GWAS Signals on Chromosome 4q$882,588
R01 · FY2022 · HL
Metabolic Control of Stemness in lung epithelial progenitors by FAM13A$667,400
R01 · FY2022 · HL · contact PI
Integrative Characterization on the function of COPD GWAS gene, HHIP$655,509
R01 · FY2022 · HL · contact PI
Genetic and Functional Dissection of a Cluster of COPD GWAS Signals on Chromosome 4q$887,786
R01 · FY2021 · HL
Metabolic Control of Stemness in lung epithelial progenitors by FAM13A$687,150
R01 · FY2021 · HL · contact PI
Integrative Characterization on the function of COPD GWAS gene, HHIP$655,509
R01 · FY2021 · HL · contact PI
Genetic and Functional Dissection of a Cluster of COPD GWAS Signals on Chromosome 4q$886,191
R01 · FY2020 · HL
Identifying functional variants in COPD GWAS loci$848,038
R01 · FY2020 · HL
Integrative Characterization on the function of COPD GWAS gene, HHIP$675,259
R01 · FY2020 · HL · contact PI
Functional Genomics$460,102
P01 · FY2020 · HL · contact PI
Identifying functional variants in COPD GWAS loci$886,769
R01 · FY2019 · HL
Genetic and Functional Dissection of a Cluster of COPD GWAS Signals on Chromosome 4q$886,191
R01 · FY2019 · HL
Functional Genomics$471,295
P01 · FY2019 · HL · contact PI
HL-FAM13A Regulates the beta-catenin/Wnt Pathway in Chronic Obstructive Pulmonary Disease$443,750
R01 · FY2019 · HL · contact PI
Identifying functional variants in COPD GWAS loci$877,981
R01 · FY2018 · HL
Functional Genomic Approaches to Dissect COPD GWAS Loci$531,313
R33 · FY2018 · HL
Functional Genomics$471,477
P01 · FY2018 · HL · contact PI
HL-FAM13A Regulates the beta-catenin/Wnt Pathway in Chronic Obstructive Pulmonary Disease$443,750
R01 · FY2018 · HL · contact PI
Identifying functional variants in COPD GWAS loci$853,683
R01 · FY2017 · HL
Functional Genomic Approaches to Dissect COPD GWAS Loci$529,538
R33 · FY2017 · HL
Functional Genomics$467,919
P01 · FY2017 · HL · contact PI
HL-FAM13A Regulates the beta-catenin/Wnt Pathway in Chronic Obstructive Pulmonary Disease$443,750
R01 · FY2017 · HL · contact PI
Functional Genomic Approaches to Dissect COPD GWAS Loci$619,147
R33 · FY2016 · HL
Functional Genomics$464,970
P01 · FY2016 · HL · contact PI
HL-FAM13A Regulates the beta-catenin/Wnt Pathway in Chronic Obstructive Pulmonary Disease$443,750
R01 · FY2016 · HL · contact PI
HL-FAM13A Regulates the beta-catenin/Wnt Pathway in Chronic Obstructive Pulmonary Disease$442,813
R01 · FY2015 · HL · contact PI
Functional Genomic Approaches to Dissect COPD GWAS Loci$222,206
R21 · FY2015 · HL
Functional Genomic Approaches to Dissect COPD GWAS Loci$255,760
R21 · FY2014 · HL